Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men
β Scribed by Kotaro Ozasa; Masahiro Nakao; Yoshiyuki Watanabe; Kyohei Hayashi; Tsuneharu Miki; Kazuya Mikami; Mitsuru Mori; Fumio Sakauchi; Masakazu Washio; Yoshinori Ito; Koji Suzuki; Kenji Wakai; Akiko Tamakoshi
- Book ID
- 108582388
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 245 KB
- Volume
- 95
- Category
- Article
- ISSN
- 1347-9032
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Objective Finasteride reduces prostate cancer risk by blocking the conversion of testosterone to dihydrotestosterone. However, whether finasteride affects estrogens levels or change in estrogens affects prostate cancer risk is unknown. ## Methods These questions were investigated in a caseβcon
## Abstract Enterolactone, a phytoestrogen belonging to the class of lignans, is produced by the intestinal microflora from precursors in plant foods and has been implicated in protection against cancer. We study the effect of enterolactone on the risk of a subsequent diagnosis of prostate cancer.